N Guanabens
Overview
Explore the profile of N Guanabens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmoral A, Peris P, Lopez Medina C, Florez H, Barcelo M, Pascual Pastor M, et al.
Osteoporos Int
. 2024 Dec;
36(2):245-254.
PMID: 39623217
Objective: The optimal length of bisphosphonate discontinuation is unknown, as is the type of patient who could benefit from this approach. The objectives of the study were to analyze, in...
2.
Florez H, Hernandez-Rodriguez J, Carrasco J, Filella X, Prieto-Gonzalez S, Monegal A, et al.
Osteoporos Int
. 2021 Sep;
33(3):745-750.
PMID: 34557953
Introduction: Osteocalcin (OC) is involved in the regulation of glucose homeostasis. Glucocorticoid (GC) treatment is associated with impaired osteoblast function, decreased OC levels, and the development and/or worsening of pre-existing...
3.
Guanabens N, Olmos J, Hernandez J, Cerda D, Hidalgo Calleja C, Martinez Lopez J, et al.
Osteoporos Int
. 2021 Jan;
32(7):1333-1342.
PMID: 33459805
Introduction: There is little quality data on the updated prevalence of fractures in rheumatoid arthritis (RA) that may have changed due to advances in the therapeutic strategy in recent years....
4.
Bianchi M, Bishop N, Guanabens N, Hofmann C, Jakob F, Roux C, et al.
Osteoporos Int
. 2020 Mar;
31(8):1445-1460.
PMID: 32162014
This article provides an overview of the current knowledge on hypophosphatasia-a rare genetic disease of very variable presentation and severity-with a special focus on adolescents and adults. It summarizes the...
5.
Gifre L, Humbert L, Muxi A, Del Rio L, Vidal J, Portell E, et al.
Osteoporos Int
. 2017 Oct;
29(1):201-209.
PMID: 29043391
Introduction: SCI is associated with a marked increase in bone loss and risk of osteoporosis development short-term after injury. 3D-DXA is a new imaging analysis technique providing 3D analysis of...
6.
Gifre L, Ruiz-Gaspa S, Carrasco J, Portell E, Vidal J, Muxi A, et al.
Osteoporos Int
. 2017 Jun;
28(9):2707-2715.
PMID: 28580511
Introduction: Bone turnover and bone loss are markedly increased shortly after SCI. However, the pathogenesis and clinical management of this process remain unclear, especially the role of the osteoprotegerin (OPG)/RANKL...
7.
Peris P, Filella X, Monegal A, Guanabens N, Foj L, Bonet M, et al.
Osteoporos Int
. 2017 May;
28(8):2457-2464.
PMID: 28466136
Introduction: Determination of 25-OH vitamin D serum levels (25-OHD) constitutes the method of choice for evaluating vitamin D deficiency. However, vitamin D-binding protein (DBP) may modulate its bioavailability thereby affecting...
8.
Diez-Perez A, Naylor K, Abrahamsen B, Agnusdei D, Brandi M, Cooper C, et al.
Osteoporos Int
. 2017 Jan;
28(3):767-774.
PMID: 28093634
Introduction: Low adherence to oral bisphosphonates is a common problem that jeopardizes the efficacy of treatment of osteoporosis. No clear screening strategy for the assessment of compliance is widely accepted...
9.
Monegal A, Peris P, Alsina M, Colmenero J, Guanabens N
Osteoporos Int
. 2016 Mar;
27(8):2631-4.
PMID: 27010647
Non-uremic calciphylaxis is a severe rare disorder characterized by ischemic necrosis. Recently, three cases of cutaneous calciphylaxis have been described in the context of teriparatide treatment. We present a 51-year-old...
10.
Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury
Gifre L, Vidal J, Carrasco J, Muxi A, Portell E, Monegal A, et al.
Osteoporos Int
. 2015 Oct;
27(1):405-10.
PMID: 26423406
Unlabelled: Osteoporosis is a frequent complication related to spinal cord injury (SCI), and data on osteoporosis treatment after SCI is scarce. Treatment with denosumab increases lumbar and femoral BMD and...